Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV 26506-9196, United States.
Department of Mechanical Engineering, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Acta Biomater. 2019 Jul 15;93:135-151. doi: 10.1016/j.actbio.2019.01.043. Epub 2019 Jan 24.
Musculoskeletal disorders are a significant burden on the global economy and public health. Advanced drug delivery plays a key role in the musculoskeletal field and holds the promise of enhancing the repair of degenerated and injured musculoskeletal tissues. Ideally, drug delivery should have the ability to directly deliver therapeutic agents to the diseased/injured sites with a desirable drug level over a period of time. Here, we present a mini-review of the current state-of-the-art research associated with local drug delivery and its use for the treatment of musculoskeletal disorders. First, an overview of drug delivery strategies, with a focus on issues related to musculoskeletal pathology, potential therapeutic strategies, conventional and non-conventional drugs, and various delivery systems, is introduced. Then, we highlight recent advances in the emerging fields of musculoskeletal local drug delivery, involving therapeutic drugs (e.g., genes, small molecule therapeutics, and stem cells), novel delivery vehicles (e.g., 3D printing and tissue engineering techniques), and innovative delivery approaches (e.g., multi-drug delivery and smart stimuli-responsive delivery). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications. STATEMENT OF SIGNIFICANCE: Three important aspects are highlighted in this manuscript: 1) The advanced musculoskeletal drug delivery is introduced from the aspects ranging from musculoskeletal disorders, potential therapeutic solutions, and various drug delivery systems. 2) The recent advances in the emerging fields of musculoskeletal local drug delivery, involving therapeutic drugs (e.g., genes, small molecule therapeutics, and stem cells), novel delivery vehicles (e.g., 3D printing and tissue engineering technique), and innovative delivery approaches (e.g., multi-drug delivery and smart stimuli-responsive delivery), are highlighted. 3) The challenges and perspectives of future research directions in the development of musculoskeletal local drug delivery are presented.
肌肉骨骼疾病是全球经济和公共卫生的重大负担。先进的药物输送在肌肉骨骼领域中起着关键作用,有望增强退变和受损肌肉骨骼组织的修复。理想情况下,药物输送应该能够将治疗剂直接递送到患病/受伤部位,并在一段时间内保持理想的药物水平。在这里,我们对与局部药物输送相关的最新研究进展进行了简要回顾,并探讨了其在肌肉骨骼疾病治疗中的应用。首先,我们介绍了药物输送策略的概述,重点介绍了与肌肉骨骼病理学相关的问题、潜在的治疗策略、常规和非传统药物以及各种输送系统。然后,我们强调了肌肉骨骼局部药物输送领域的最新进展,涉及治疗药物(如基因、小分子治疗药物和干细胞)、新型输送载体(如 3D 打印和组织工程技术)和创新的输送方法(如多药物输送和智能刺激响应性输送)。最后,本文总结了未来的展望以及开发肌肉骨骼应用局部药物输送所面临的挑战。
意义陈述:本文强调了三个重要方面:1)从肌肉骨骼疾病、潜在治疗解决方案和各种药物输送系统等方面介绍了先进的肌肉骨骼药物输送。2)突出了肌肉骨骼局部药物输送新兴领域的最新进展,涉及治疗药物(如基因、小分子治疗药物和干细胞)、新型输送载体(如 3D 打印和组织工程技术)和创新的输送方法(如多药物输送和智能刺激响应性输送)。3)提出了肌肉骨骼局部药物输送开发未来研究方向的挑战和展望。